Lionheart Health Advances in $101M XPRIZE Competition with Groundbreaking Regenerative Technology
May 21st, 2025 12:00 PM
By: Newsworthy Staff
Lionheart Health has been selected as one of 40 semi-finalists in the XPRIZE Healthspan Competition, aiming to develop a treatment that can restore muscle, cognitive, and immune function in individuals aged 50-80 by up to 20 years. The company's innovative bioelectric signaling technology represents a potential breakthrough in extending human healthspan.

Biotechnology company Lionheart Health has emerged as a top contender in the prestigious $101 million XPRIZE Healthspan Competition, offering potential hope for extending human longevity and functional health. Selected from a global pool of 596 teams representing 53 countries, the company will receive $250,000 as a semi-finalist and advance to the next phase of the competition.
The XPRIZE challenge demands a transformative medical intervention that can restore multiple physiological functions in aging individuals. Specifically, participants must demonstrate a treatment capable of reversing aging markers by at least 10 years, with an ambitious goal of a 20-year restoration, within a one-year treatment protocol for people aged 50-80.
Lionheart Health's proprietary technology platform leverages precise bioelectric signaling sequences to control protein release and regeneration. Central to their approach is the utilization of Klotho-expressing stem cells suspended in a specialized nutrient hydrogel. Recent scientific research has highlighted the Klotho protein's significant role in aging, showing promising results in extending lifespan and improving cognitive function across animal models.
The company's innovative approach combines cutting-edge biotechnology with a deep understanding of cellular regeneration. Dr. Leslie Miller, Lionheart Health's Chief Medical Officer, emphasized that their solution harnesses the body's natural healing processes to promote renewal and regeneration.
Moving forward, Lionheart Health will need to demonstrate its healthspan extension protocol through a rigorous, IRB-approved clinical study. The company's long-term vision extends beyond this competition, with plans to develop a comprehensive whole-body regeneration chamber and establish 124 MedSpa clinics specializing in longevity protocols over the next five years.
This advancement represents more than just a potential medical breakthrough; it signals a significant step toward understanding and potentially reversing the aging process. By targeting muscle, cognitive, and immune function restoration, Lionheart Health's technology could revolutionize approaches to aging, offering hope for maintaining physical and mental vitality well into later life stages.
Source Statement
This news article relied primarily on a press release disributed by Newsworthy.ai. You can read the source press release here,
